Systematic review of lapatinib in combination with letrozole compared with other first-line treatments for hormone receptor positive(HR+) and HER2+ advanced or metastatic breast cancer(MBC)

Rob Riemsma*, Carol A. Forbes, Mayur M. Amonkar, Konstantinos Lykopoulos, Jose R. Diaz, Jos Kleijnen, Daniel Rea

*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

20 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Systematic review of lapatinib in combination with letrozole compared with other first-line treatments for hormone receptor positive(HR+) and HER2+ advanced or metastatic breast cancer(MBC)'. Together they form a unique fingerprint.

Medicine & Life Sciences